We predicted that the primary mechanism of action of andrographolide in the treatment of GC is mediated by HIF-1, PI3K-AKT and other signaling pathways to regulate the proliferation, apoptosis, migration, and angiogenesis of tumour cells, thus playing a role in the treatment of GC. The gene discussed is PIK3CA; the disease is gastric cancer.